In NSCLC cells, ginsenoside Rg3 may increase Bax level and activate Caspase-3 in cells and decrease the expression of the anti-apoptotic protein (Bcl-2) [659]. This evidence concerns the gene BCL2 and non-small cell lung carcinoma.